Financhill
Sell
28

RCKT Quote, Financials, Valuation and Earnings

Last price:
$3.51
Seasonality move :
4.26%
Day range:
$3.28 - $3.55
52-week range:
$2.19 - $13.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.19x
Volume:
1.7M
Avg. volume:
2.1M
1-year change:
-69.82%
Market cap:
$373.4M
Revenue:
--
EPS (TTM):
-$2.25

Earnings Data

Next earnings date for RCKT
Feb 26
2026
Most recent earnings per share
-$0.45
Beat by $0.07
(Nov 6/2025)
Consensus Estimate
-$0.52
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RCKT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 -- -- -- -$0.44 --
11/06/2025 Q3 $250K -- -$0.45 -$0.52 $0.07
08/07/2025 Q2 $4.4M -- -$0.62 -$0.53 -$0.09
05/09/2025 Q1 $800K -- -$0.56 -$0.58 $0.03
02/27/2025 Q4 $31.3K -- -$0.62 -$0.72 $0.10
11/07/2024 Q3 -- -- -$0.71 -$0.75 $0.04
08/05/2024 Q2 -- -- -$0.74 -$0.72 -$0.02
05/06/2024 Q1 -- -- -$0.66 -$0.67 $0.01
02/26/2024 Q4 -- -- -$0.64 -$0.77 $0.13
11/06/2023 Q3 -- -- -$0.75 -$0.78 $0.03
08/09/2023 Q2 -- -- -$0.82 -$0.78 -$0.04
05/04/2023 Q1 -- -- -$0.73 -$0.84 $0.11
02/27/2023 Q4 -- -- -$0.89 -$0.82 -$0.07
11/03/2022 Q3 -- -- -$0.87 -$0.77 -$0.10
08/08/2022 Q2 -- -- -$0.83 -$0.68 -$0.15
05/06/2022 Q1 -- -- -$0.67 -$0.70 $0.03
02/24/2022 Q4 -- -- -$0.69 -$0.73 $0.04
11/05/2021 Q3 -- -- -$0.79 -$0.62 -$0.17
08/09/2021 Q2 -- -- -$0.55 -$0.65 $0.10
05/10/2021 Q1 -- -- -$0.65 -$0.69 $0.04
02/25/2021 Q4 -- -- -$1.09 -$0.50 -$0.59
11/04/2020 Q3 -- -- -$0.53 -$0.45 -$0.08
08/05/2020 Q2 -- -- -$0.45 -$0.50 $0.05
05/06/2020 Q1 -- -- -$0.45 -$0.45 --
03/05/2020 Q4 -- -- -$0.39 -$0.48 $0.09
11/07/2019 Q3 -- -- -$0.38 -$0.48 $0.10
08/07/2019 Q2 -- -- -$0.38 -$0.61 $0.23
05/08/2019 Q1 -- -- -$0.43 -$0.53 $0.10
03/07/2019 Q4 -- -- -$0.66 -$0.44 -$0.22
11/07/2018 Q3 -- -- -$0.40 -$0.44 $0.04
08/08/2018 Q2 -- -- -$0.40 -$0.44 $0.04
05/11/2018 Q1 -- -- -$0.28 -$0.39 $0.11
03/06/2018 Q4 -- -- -$0.18 -$0.31 $0.13

Rocket Pharmaceuticals, Inc. Earnings Questions

  • How Much did Rocket Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Rocket Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Rocket Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Rocket Pharmaceuticals, Inc. announced earnings per share of -$0.45 which represents a beat of analyst forecast a -$0.52 per share.

  • Is Rocket Pharmaceuticals, Inc. Profitable?

    Rocket Pharmaceuticals, Inc. reported -$3.2M that represents -$0.03 per share over the last quarter.

  • What is the Analyst Consensus for Rocket Pharmaceuticals, Inc. EPS Next Year?

    Rocket Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.73 per share to -$2.80 per share next year representing a decrease of -26.01%.

  • When is Rocket Pharmaceuticals, Inc.'s Earnings Date?

    Rocket Pharmaceuticals, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock